{
Bristol-Myers Squibb Company

Companies

}
001122334455554433221100
001122334455554433221100

global cancer immunotherapy market projected to reach 236.9 billion by 2030

The global cancer immunotherapy market is projected to reach $135.2 billion in 2024, growing at a CAGR of 9.8% to $236.9 billion by 2030, driven by rising cancer prevalence and demand for effective treatments. North America leads the market, while Asia-Pacific is the fastest-growing region. Monoclonal antibodies dominate the product segment, with lung cancer applications holding the largest market share, and breast cancer expected to grow the fastest.
GlobeNewswire News Room
United States Dollar GSK plc Bristol-Myers Squibb Company Bayer AG Eli Lilly and Company Pfizer Inc. Merck & Co., Inc. Novartis AG Immunocore Holdings plc AstraZeneca PLC Amgen Inc. F. Hoffmann-La Roche Ltd. IND FRA ARG CAN ESP USA BRA CHN MEX DEU ITA JPN GBR KOR Show more
Healthcare, Market Report
10:06 10.01.2025

semaglutides market projected to reach 36.87 billion by 2028

The semaglutides market is projected to grow from $20.54 billion in 2023 to $36.87 billion by 2028, driven by rising diabetes prevalence and increased demand for effective treatments. Key players are innovating with GLP-1 receptor analogues and oral formulations to enhance patient adherence and reduce side effects. North America leads the market, while Asia-Pacific is expected to be the fastest-growing region.
GlobeNewswire News Room
United States Dollar Adocia SA Sanofi SA Eli Lilly and Company Roche Holding AG Pfizer Inc. Merck & Co., Inc. Dr. Reddy's Laboratories Limited Boehringer Ingelheim International GmbH Glaxosmithkline plc Takeda Pharmaceutical Company Limited AbbVie Inc. Novartis International AG Bristol-Myers Squibb Company Novo Nordisk A/S Cipla Limited Biocon Limited Teva Pharmaceutical Industries Ltd AstraZeneca PLC Amgen Inc. ITA IND FRA IDN CAN ESP BRA USA RUS CHN DEU AUS JPN GBR KOR Show more
Healthcare, Market Report
10:12 06.01.2025

market insights microns outlook falters as fed rate cuts impact stocks

Micron's stock plummeted over 11% after it reported strong earnings but lowered its outlook, particularly citing weak demand for NAND memory chips. The Federal Reserve's interest rate cuts are impacting homebuilders like Lennar, which reported earnings below expectations due to affordability issues. Meanwhile, the S&P 500 Short Range Oscillator indicates the market is oversold, and speculative sectors are under scrutiny as the Dow faces its worst losing streak since 1974.
CNBC
United States Dollar Nextracker Inc. Danaher Corporation Bank of America Corporation Micron Technology, Inc. Lennar Corporation Affirm Holdings, Inc. Bristol-Myers Squibb Company SoFi Technologies, Inc. USA Donald Trump Sanjay Mehrotra Show more
Finance & Economy, Market Report
14:59 19.12.2024

topical corticosteroids market poised for growth with emerging opportunities and trends

The global Topical Corticosteroids market, valued at approximately US$ 4.12 billion in 2022, is projected to grow at a CAGR of 4.36% through 2030. The report provides an extensive analysis of market dynamics, competitive landscape, and consumption trends, highlighting key players like GlaxoSmithKline and Merck & Co. It also explores opportunities for growth driven by increasing demand across various industries, while addressing challenges such as supply chain disruptions and changing consumer preferences.
openPR.com
Merck & Co., Inc. AstraZeneca PLC Almirall S.A. A Bristol-Myers Squibb Company Glaxosmithkline plc Leo Pharma AB Bausch Health Companies Inc. IND GBR CAN SAU JPN BRA DEU FRA MEX CHN USA Viju Shah Alice Mutum Show more
Healthcare, Market Report
11:04 13.12.2024

wireless healthcare market poised for rapid growth driven by innovative technologies

The wireless healthcare market is projected to grow from $174.27 billion in 2023 to $205.78 billion in 2024, driven by the demand for remote access via mobile phones and innovations in wearable health devices. By 2028, the market is expected to reach $422.16 billion, fueled by global health responses and advancements in digital therapeutics. Key players include AT&T, Cerner, and Qualcomm, among others, highlighting a competitive landscape focused on enhancing healthcare delivery through technology.
openPR.com
AT&T Inc. Verizon Communications Inc. Qualcomm Inc Cisco Systems Inc Motorola Solutions Inc GE HealthCare Technologies Inc. International Business Machines Corporation Honeywell International Inc. AstraZeneca PLC Bristol-Myers Squibb Company Eli Lilly and Company UnitedHealth Group Inc Anthem Inc. Humana Inc. Cigna Corporation CVS Health Corporation Walgreens Boots Alliance Inc Rite Aid Corporation HCA Healthcare Inc Tenet Healthcare Corporation Show more
Technology & Innovation, Market Report
07:50 29.11.2024

AstraZeneca's Enhertu approved for reimbursement in China amid ongoing probe

AstraZeneca’s Enhertu, a leading breast cancer treatment, has been approved for reimbursement by China’s state-run medical insurance, enhancing the company’s sales prospects amid an ongoing investigation involving some senior executives. The drug is one of 91 added to the National Reimbursement Drug List, effective January 1, alongside treatments from Johnson & Johnson, Bristol Myers Squibb, Roche, Sanofi, and Merck for various conditions.
Bloomberg.com
United States Dollar Sanofi Merck & Co., Inc. Bristol-Myers Squibb Company Roche Holding AG AstraZeneca PLC Johnson & Johnson GBR Brian Johnson Show more
Healthcare, News Article
08:22 28.11.2024

consumer healthcare market poised for rapid growth driven by digital innovations

The consumer healthcare market is projected to grow significantly, reaching $1,476.45 billion by 2028, with a CAGR of 22.1%. Key drivers include an aging population, increased reliance on OTC medications, and the rise of e-commerce. Major players like Johnson & Johnson and Sanofi are adapting to trends in digital health and personalized care solutions.
EIN News
United States Dollar Perrigo Company plc Cardinal Health, Inc. Johnson & Johnson Church & Dwight Co., Inc. Herbalife Nutrition Ltd. Nestlé S.A. Abbott Laboratories Teva Pharmaceutical Industries Ltd. AstraZeneca PLC DSM Nutritional Products AG Pfizer Inc. Colgate-Palmolive Company AbbVie Inc. Bayer AG BASF SE Glaxosmithkline plc Novartis International AG CVS Health Corporation Boehringer Ingelheim International GmbH Sanofi Amway Corporation Novo Nordisk A/S Ipsen S.A. Bristol-Myers Squibb Company McKesson Corporation Merck & Co., Inc. The Clorox Company Reckitt Benckiser Group plc Cigna Corporation Eli Lilly and Company Brian Johnson Show more
Healthcare, Market Report
00:30 27.11.2024

healthcare nanotechnology market poised for rapid growth driven by cancer cases

The healthcare nanotechnology market is projected to grow from $308.03 billion in 2023 to $351.82 billion in 2024, with a CAGR of 14.2%, driven by rising cancer cases and advancements in nanomedicine. By 2028, the market is expected to reach $613.9 billion, fueled by innovations in theranostics and personalized medicine. North America led the market in 2023, highlighting the region's significant role in this expanding field.
openPR.com
United States Dollar Luminex Corporation Sanofi Mallinckrodt plc Abbott Laboratories Teva Pharmaceutical Industries Ltd. Bristol-Myers Squibb Company Pfizer Inc. Merck & Co., Inc. Johnson & Johnson Inc. Celgene Corporation GE HealthCare Technologies Inc. Show more
Healthcare, Market Report
15:59 22.11.2024

rth america oncology drugs market projected to reach 27.20 billion by 2033

The North America oncology drugs market, valued at USD 10.13 billion in 2023, is projected to grow at a CAGR of 10.38%, reaching USD 27.20 billion by 2033. Key drivers include advances in cancer research, rising cancer prevalence, and increasing demand for personalized medicine, while challenges include high drug costs and stringent regulations. The market is segmented into cytotoxic, targeted, and hormonal drugs, with targeted therapies expected to dominate due to their effectiveness and reduced toxicity.
Spherical Insights
United States Dollar Novartis AG Gilead Sciences, Inc. Sanofi Takeda Pharmaceutical Company Limited Johnson & Johnson Amgen Inc. Bristol-Myers Squibb Company Biogen Inc. AstraZeneca PLC Roche Holding AG Pfizer Inc. Merck & Co., Inc. Celgene Corporation AbbVie Inc. Eli Lilly and Company USA Show more
Healthcare, Market Report
14:29 22.11.2024

global pediatric healthcare market poised for significant growth through 2032

The Global Pediatric Healthcare market is projected to grow from $175.6 billion in 2024 to $290 billion by 2032, with a CAGR of 6.5%. Key players include Abbott, Pfizer, and Merck, focusing on pharmaceuticals, nutrition, medical devices, and vaccines across various applications like hospitals and homecare. The market is expanding rapidly in the Asia-Pacific region, while North America remains the dominant market.
openPR.com
Siemens Healthineers AG Pfizer Inc. Medtronic Johnson & Johnson Danone S.A. Philips Merck & Co., Inc. GlaxoSmithKline Nestlé S.A. The Procter & Gamble Company GE HealthCare Technologies Inc. Reckitt Benckiser Group plc Bristol-Myers Squibb Company Sanofi Boston Scientific Corporation Hoffmann-La Roche AG Abbott Novartis AG Bayer USA IND VNM THA IDN SGP MYS JPN KOR HKG AUS PHL TWN CHN Nidhi Bhawsar Show more
Healthcare, Market Report
17:31 20.11.2024
Trending
Subcategory
Corporate News Stock Market Updates Industry Trends Industry Mergers & Acquisitions Finance Mergers & Acquisitions Domestic Politics Banking Regulations Global Financial Events Retail and Consumer Goods CEO Changes Government Policies Workplace Trends Global Trade Developments Startups & Entrepreneurship Elections & Campaigns Market Analysis and Predictions Central Bank Actions Government Economic Policies Supply Chain Management Hedge Funds & Private Equity
Countries:
USA ITA CHN GBR CHE DEU FRA IND JPN KOR SGP MEX CAN ESP VNM HKG ARE SAU BEL AUS
Companies:
Tesla, Inc. UniCredit S.p.A. Banco BPM S.p.A. Deutsche Bank Money Market PP JPMorgan Chase & Co. Apple Inc. Barclays PLC Credit Suisse Strategic Income I CREDIT AGRICOLE SpaceXCoin USD Lloyds Banking Group plc BNP Paribas SA Amazon.com, Inc. The Goldman Sachs Group, Inc. UBS Group AG Credit Agricole Banco Santander, S.A. Reinsurance Group of America, Incorporated Google Inc. Berkshire Hathaway Inc.
Currencies:
United States Dollar Euro British Pound Sterling Swiss Franc Chinese Yuan Indian Rupee Japanese Yen South Korean Won Offshore Chinese Yuan Hong Kong Dollar Singapore Dollar Australian Dollar Norwegian Krone Filipino Peso Canadian Dollar Danish Krone Swedish Krona Mexican Peso Indonesian Rupiah New Taiwan Dollar
People:
Donald Trump Elon Musk Susan P. Crawford Brad Schimel Andrea Orcel Karoline Leavitt Warren Buffett Sergio Ermotti Mike Waltzer Matt Gaetz Dan Ives Joe Biden Kamala Harris JD Vance Valentina Za Giulia Segreti Robin Leopold Desiree Fixler Bret Baier Jimmy Patronis

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.